Logo image of CRL.MI

CAREL INDUSTRIES SPA (CRL.MI) Stock Fundamental Analysis

Europe - BIT:CRL - IT0005331019 - Common Stock

21.85 EUR
-0.6 (-2.67%)
Last: 11/4/2025, 7:00:00 PM
Fundamental Rating

5

Taking everything into account, CRL scores 5 out of 10 in our fundamental rating. CRL was compared to 21 industry peers in the Building Products industry. CRL has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. CRL is quite expensive at the moment. It does show a decent growth rate. With these ratings, CRL could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year CRL was profitable.
In the past year CRL had a positive cash flow from operations.
Each year in the past 5 years CRL has been profitable.
Each year in the past 5 years CRL had a positive operating cash flow.
CRL.MI Yearly Net Income VS EBIT VS OCF VS FCFCRL.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

1.2 Ratios

CRL's Return On Assets of 7.29% is amongst the best of the industry. CRL outperforms 80.95% of its industry peers.
CRL's Return On Equity of 14.29% is fine compared to the rest of the industry. CRL outperforms 71.43% of its industry peers.
CRL's Return On Invested Capital of 8.69% is fine compared to the rest of the industry. CRL outperforms 71.43% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CRL is in line with the industry average of 10.84%.
Industry RankSector Rank
ROA 7.29%
ROE 14.29%
ROIC 8.69%
ROA(3y)8.19%
ROA(5y)8.54%
ROE(3y)21.17%
ROE(5y)23.44%
ROIC(3y)11.78%
ROIC(5y)12.59%
CRL.MI Yearly ROA, ROE, ROICCRL.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

With an excellent Profit Margin value of 10.34%, CRL belongs to the best of the industry, outperforming 80.95% of the companies in the same industry.
CRL's Profit Margin has been stable in the last couple of years.
Looking at the Operating Margin, with a value of 11.63%, CRL belongs to the top of the industry, outperforming 85.71% of the companies in the same industry.
In the last couple of years the Operating Margin of CRL has declined.
CRL has a Gross Margin (45.73%) which is comparable to the rest of the industry.
CRL's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 11.63%
PM (TTM) 10.34%
GM 45.73%
OM growth 3Y-8.96%
OM growth 5Y-3.73%
PM growth 3Y-2.46%
PM growth 5Y0.24%
GM growth 3Y2.57%
GM growth 5Y4.66%
CRL.MI Yearly Profit, Operating, Gross MarginsCRL.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CRL is still creating some value.
The number of shares outstanding for CRL remains at a similar level compared to 1 year ago.
CRL has more shares outstanding than it did 5 years ago.
CRL has a better debt/assets ratio than last year.
CRL.MI Yearly Shares OutstandingCRL.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
CRL.MI Yearly Total Debt VS Total AssetsCRL.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 5.55 indicates that CRL is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.55, CRL belongs to the top of the industry, outperforming 85.71% of the companies in the same industry.
The Debt to FCF ratio of CRL is 1.66, which is an excellent value as it means it would take CRL, only 1.66 years of fcf income to pay off all of its debts.
CRL has a better Debt to FCF ratio (1.66) than 95.24% of its industry peers.
CRL has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.21, CRL belongs to the best of the industry, outperforming 80.95% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 1.66
Altman-Z 5.55
ROIC/WACC1.12
WACC7.79%
CRL.MI Yearly LT Debt VS Equity VS FCFCRL.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.3 Liquidity

CRL has a Current Ratio of 1.58. This is a normal value and indicates that CRL is financially healthy and should not expect problems in meeting its short term obligations.
CRL has a Current ratio of 1.58. This is comparable to the rest of the industry: CRL outperforms 57.14% of its industry peers.
CRL has a Quick Ratio of 1.13. This is a normal value and indicates that CRL is financially healthy and should not expect problems in meeting its short term obligations.
CRL has a Quick ratio of 1.13. This is in the better half of the industry: CRL outperforms 76.19% of its industry peers.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 1.13
CRL.MI Yearly Current Assets VS Current LiabilitesCRL.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

5

3. Growth

3.1 Past

CRL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -19.15%.
The Earnings Per Share has been growing by 9.70% on average over the past years. This is quite good.
The Revenue has decreased by -2.99% in the past year.
The Revenue has been growing by 12.06% on average over the past years. This is quite good.
EPS 1Y (TTM)-19.15%
EPS 3Y5.31%
EPS 5Y9.7%
EPS Q2Q%50.45%
Revenue 1Y (TTM)-2.99%
Revenue growth 3Y11.23%
Revenue growth 5Y12.06%
Sales Q2Q%9.42%

3.2 Future

Based on estimates for the next years, CRL will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.02% on average per year.
The Revenue is expected to grow by 8.47% on average over the next years. This is quite good.
EPS Next Y-4.23%
EPS Next 2Y7.3%
EPS Next 3Y10.02%
EPS Next 5YN/A
Revenue Next Year7.79%
Revenue Next 2Y8.61%
Revenue Next 3Y8.47%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CRL.MI Yearly Revenue VS EstimatesCRL.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
CRL.MI Yearly EPS VS EstimatesCRL.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 39.02, CRL can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of CRL indicates a slightly more expensive valuation: CRL is more expensive than 61.90% of the companies listed in the same industry.
CRL's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 26.03.
CRL is valuated quite expensively with a Price/Forward Earnings ratio of 33.89.
CRL's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. CRL is more expensive than 66.67% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.27. CRL is valued rather expensively when compared to this.
Industry RankSector Rank
PE 39.02
Fwd PE 33.89
CRL.MI Price Earnings VS Forward Price EarningsCRL.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CRL is valued more expensive than 80.95% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CRL is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 28.34
EV/EBITDA 23.34
CRL.MI Per share dataCRL.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

The decent profitability rating of CRL may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)4.02
EPS Next 2Y7.3%
EPS Next 3Y10.02%

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.73%, CRL is not a good candidate for dividend investing.
CRL's Dividend Yield is slightly below the industry average, which is at 4.07.
Compared to an average S&P500 Dividend Yield of 2.38, CRL's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.73%

5.2 History

On average, the dividend of CRL grows each year by 14.04%, which is quite nice.
Dividend Growth(5Y)14.04%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

30.38% of the earnings are spent on dividend by CRL. This is a low number and sustainable payout ratio.
CRL's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP30.38%
EPS Next 2Y7.3%
EPS Next 3Y10.02%
CRL.MI Yearly Income VS Free CF VS DividendCRL.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CRL.MI Dividend Payout.CRL.MI Dividend Payout, showing the Payout Ratio.CRL.MI Dividend Payout.PayoutRetained Earnings

CAREL INDUSTRIES SPA

BIT:CRL (11/4/2025, 7:00:00 PM)

21.85

-0.6 (-2.67%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)08-01 2025-08-01
Earnings (Next)11-13 2025-11-13
Inst Owners26.81%
Inst Owner ChangeN/A
Ins Owners52.75%
Ins Owner ChangeN/A
Market Cap2.46B
Revenue(TTM)593.19M
Net Income(TTM)61.32M
Analysts72
Price Target24.17 (10.62%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.73%
Yearly Dividend0.19
Dividend Growth(5Y)14.04%
DP30.38%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.67%
Min Revenue beat(2)-5.31%
Max Revenue beat(2)-2.03%
Revenue beat(4)0
Avg Revenue beat(4)-3.4%
Min Revenue beat(4)-5.31%
Max Revenue beat(4)-1.82%
Revenue beat(8)2
Avg Revenue beat(8)-2.93%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.34%
PT rev (3m)8.55%
EPS NQ rev (1m)-13.33%
EPS NQ rev (3m)-13.33%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.3%
Revenue NQ rev (1m)-4.94%
Revenue NQ rev (3m)-4.94%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.01%
Valuation
Industry RankSector Rank
PE 39.02
Fwd PE 33.89
P/S 4.14
P/FCF 28.34
P/OCF 21.53
P/B 5.73
P/tB 41.7
EV/EBITDA 23.34
EPS(TTM)0.56
EY2.56%
EPS(NY)0.64
Fwd EY2.95%
FCF(TTM)0.77
FCFY3.53%
OCF(TTM)1.01
OCFY4.64%
SpS5.27
BVpS3.81
TBVpS0.52
PEG (NY)N/A
PEG (5Y)4.02
Graham Number6.93
Profitability
Industry RankSector Rank
ROA 7.29%
ROE 14.29%
ROCE 10.92%
ROIC 8.69%
ROICexc 10.39%
ROICexgc 34.66%
OM 11.63%
PM (TTM) 10.34%
GM 45.73%
FCFM 14.62%
ROA(3y)8.19%
ROA(5y)8.54%
ROE(3y)21.17%
ROE(5y)23.44%
ROIC(3y)11.78%
ROIC(5y)12.59%
ROICexc(3y)15.05%
ROICexc(5y)17.4%
ROICexgc(3y)43.53%
ROICexgc(5y)43.91%
ROCE(3y)14.8%
ROCE(5y)15.83%
ROICexgc growth 3Y-17.51%
ROICexgc growth 5Y-0.61%
ROICexc growth 3Y-24.29%
ROICexc growth 5Y-10.93%
OM growth 3Y-8.96%
OM growth 5Y-3.73%
PM growth 3Y-2.46%
PM growth 5Y0.24%
GM growth 3Y2.57%
GM growth 5Y4.66%
F-Score6
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 1.66
Debt/EBITDA 0.83
Cap/Depr 66.97%
Cap/Sales 4.62%
Interest Coverage 15.41
Cash Conversion 103.86%
Profit Quality 141.48%
Current Ratio 1.58
Quick Ratio 1.13
Altman-Z 5.55
F-Score6
WACC7.79%
ROIC/WACC1.12
Cap/Depr(3y)91.98%
Cap/Depr(5y)87.52%
Cap/Sales(3y)4.87%
Cap/Sales(5y)4.61%
Profit Quality(3y)86.55%
Profit Quality(5y)91.31%
High Growth Momentum
Growth
EPS 1Y (TTM)-19.15%
EPS 3Y5.31%
EPS 5Y9.7%
EPS Q2Q%50.45%
EPS Next Y-4.23%
EPS Next 2Y7.3%
EPS Next 3Y10.02%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.99%
Revenue growth 3Y11.23%
Revenue growth 5Y12.06%
Sales Q2Q%9.42%
Revenue Next Year7.79%
Revenue Next 2Y8.61%
Revenue Next 3Y8.47%
Revenue Next 5YN/A
EBIT growth 1Y-15.06%
EBIT growth 3Y1.26%
EBIT growth 5Y7.88%
EBIT Next Year86.33%
EBIT Next 3Y32.51%
EBIT Next 5YN/A
FCF growth 1Y46.46%
FCF growth 3Y14.88%
FCF growth 5Y15.64%
OCF growth 1Y34.27%
OCF growth 3Y16.42%
OCF growth 5Y11.49%

CAREL INDUSTRIES SPA / CRL.MI FAQ

What is the fundamental rating for CRL stock?

ChartMill assigns a fundamental rating of 5 / 10 to CRL.MI.


Can you provide the valuation status for CAREL INDUSTRIES SPA?

ChartMill assigns a valuation rating of 1 / 10 to CAREL INDUSTRIES SPA (CRL.MI). This can be considered as Overvalued.


How profitable is CAREL INDUSTRIES SPA (CRL.MI) stock?

CAREL INDUSTRIES SPA (CRL.MI) has a profitability rating of 7 / 10.


What is the valuation of CAREL INDUSTRIES SPA based on its PE and PB ratios?

The Price/Earnings (PE) ratio for CAREL INDUSTRIES SPA (CRL.MI) is 39.02 and the Price/Book (PB) ratio is 5.73.


How financially healthy is CAREL INDUSTRIES SPA?

The financial health rating of CAREL INDUSTRIES SPA (CRL.MI) is 7 / 10.